Guest User

April 4, 2022

Background

Induction for ANCA-Associated Vasculitis: It’s ComPLEX

Guest User

April 4, 2022

Background

Induction for ANCA-Associated Vasculitis: It’s ComPLEX

This week we discuss an updated systematic review and meta-analysis on the effects of plasma exchange in patients with ANCA-associated vasculitis

swapnil hiremath

February 8, 2022

Background

Revisiting the Ideal Time: The Case of Chronic Dialysis

swapnil hiremath

February 8, 2022

Background

Revisiting the Ideal Time: The Case of Chronic Dialysis

This week, we will discuss the intricate analysis using target trial emulation - applied for the initiation of dialysis in CKD. Let’s fix problems of lead time and immortal time bias.

swapnil hiremath

January 26, 2021

Background

Alerting AKI and Avoiding Adverse Aftermaths

swapnil hiremath

January 26, 2021

Background

Alerting AKI and Avoiding Adverse Aftermaths

This week we discuss the AKi Alert trial from BMJ. Surely alerting us to AKI earlier will be helpful, right? Maybe - or maybe not. Join us to discuss this very important trial with some counter intuitive results.

joel topf

June 25, 2019

Background

How Long is too Long? Steroids in Nephrotic Syndrome

joel topf

June 25, 2019

Background

How Long is too Long? Steroids in Nephrotic Syndrome

This week, we will discuss an RCT, a pediatric RCT, and a pediatric RCT in childhood nephrotic syndrome! A trial that asks a question of burning importance to the management of childhood nephrotic syndrome. Join us as we tackle PREDNOS.

swapnil hiremath

April 25, 2017

Commentary

The ACEi/ARB & Rise in Creatinine Controversy: An Author Commentary

swapnil hiremath

April 25, 2017

Commentary

In a NephJC first, first author, Laurie Tomlinson wrote up some comments on the implications of her study.

swapnil hiremath

April 24, 2017

Background

ACEi, ARBs the Change in Creatinine, and the Future Risk of Outcomes

swapnil hiremath

April 24, 2017

Background

ACEi, ARBs the Change in Creatinine, and the Future Risk of Outcomes

ACEi, ARBs, the increase in creatinine and health outcomes: Now for some retrospective data.